Dynatronics Corporation (DYNT)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -2.27 Million USD | 53.15% |
| 2023 | -4.85 Million USD | -1.99% |
| 2022 | -4.75 Million USD | -26.52% |
| 2021 | -3.76 Million USD | -25.63% |
| 2020 | -2.99 Million USD | -276.01% |
| 2019 | -796 Thousand USD | 36.37% |
| 2018 | -1.25 Million USD | 25.29% |
| 2017 | -1.67 Million USD | 1.21% |
| 2016 | -1.69 Million USD | -55.93% |
| 2015 | -1.08 Million USD | -485.02% |
| 2014 | -185.79 Thousand USD | -277.36% |
| 2013 | 104.75 Thousand USD | 297.28% |
| 2012 | 26.36 Thousand USD | -96.06% |
| 2011 | 669.64 Thousand USD | -38.5% |
| 2010 | 1.08 Million USD | 53.92% |
| 2009 | 707.4 Thousand USD | 107.59% |
| 2008 | -9.32 Million USD | -7488.74% |
| 2007 | -122.84 Thousand USD | -141.5% |
| 2006 | 296.01 Thousand USD | -76.28% |
| 2005 | 1.24 Million USD | -18.15% |
| 2004 | 1.52 Million USD | 662.3% |
| 2003 | 200.01 Thousand USD | -74.17% |
| 2002 | 774.34 Thousand USD | -5.57% |
| 2001 | 820.04 Thousand USD | 50.57% |
| 2000 | 544.63 Thousand USD | -63.69% |
| 1999 | 1.5 Million USD | 36.36% |
| 1998 | 1.1 Million USD | 83.33% |
| 1997 | 600 Thousand USD | 200.0% |
| 1996 | 200 Thousand USD | -33.33% |
| 1995 | 300 Thousand USD | 150.0% |
| 1994 | -600 Thousand USD | -400.0% |
| 1993 | 200 Thousand USD | -71.43% |
| 1992 | 700 Thousand USD | 40.0% |
| 1991 | 500 Thousand USD | -16.67% |
| 1990 | 600 Thousand USD | -40.0% |
| 1989 | 1 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -240 Thousand USD | 89.81% |
| 2024 Q3 | -571.96 Thousand USD | 36.57% |
| 2024 Q4 | -559 Thousand USD | 2.11% |
| 2024 Q2 | -901.71 Thousand USD | -275.71% |
| 2023 Q1 | -474.99 Thousand USD | 68.07% |
| 2023 FY | -4.85 Million USD | -1.99% |
| 2023 Q2 | -799.52 Thousand USD | -68.32% |
| 2023 Q3 | -1.22 Million USD | -52.84% |
| 2023 Q4 | -2.35 Million USD | -92.8% |
| 2022 FY | -4.75 Million USD | -26.52% |
| 2022 Q1 | -432.31 Thousand USD | 80.52% |
| 2022 Q2 | -1.4 Million USD | -224.04% |
| 2022 Q3 | -1.43 Million USD | -2.47% |
| 2022 Q4 | -1.48 Million USD | -3.61% |
| 2021 FY | -3.76 Million USD | -25.63% |
| 2021 Q1 | -343.67 Thousand USD | -107.2% |
| 2021 Q2 | -596.86 Thousand USD | -73.67% |
| 2021 Q3 | -600.09 Thousand USD | -0.54% |
| 2021 Q4 | -2.21 Million USD | -269.91% |
| 2020 Q3 | -962.9 Thousand USD | -2886.32% |
| 2020 Q1 | 229.31 Thousand USD | 167.26% |
| 2020 Q2 | -32.24 Thousand USD | -114.06% |
| 2020 FY | -2.99 Million USD | -276.01% |
| 2020 Q4 | 4.77 Million USD | 595.65% |
| 2019 Q3 | -412.93 Thousand USD | -344.95% |
| 2019 Q4 | -340.95 Thousand USD | 17.43% |
| 2019 FY | -796 Thousand USD | 36.37% |
| 2019 Q1 | 50.6 Thousand USD | 111.04% |
| 2019 Q2 | -92.8 Thousand USD | -283.4% |
| 2018 Q3 | -1.16 Million USD | -1191.31% |
| 2018 Q4 | -458.17 Thousand USD | 60.65% |
| 2018 FY | -1.25 Million USD | 25.29% |
| 2018 Q1 | 264.84 Thousand USD | 140.35% |
| 2018 Q2 | 106.68 Thousand USD | -59.72% |
| 2017 FY | -1.67 Million USD | 1.21% |
| 2017 Q4 | -656.38 Thousand USD | 3.77% |
| 2017 Q3 | -682.07 Thousand USD | -680.36% |
| 2017 Q1 | -248.55 Thousand USD | 78.48% |
| 2017 Q2 | -87.4 Thousand USD | 64.83% |
| 2016 FY | -1.69 Million USD | -55.93% |
| 2016 Q4 | -1.15 Million USD | -200.88% |
| 2016 Q3 | -383.81 Thousand USD | -734.07% |
| 2016 Q2 | -46.01 Thousand USD | 58.24% |
| 2016 Q1 | -110.18 Thousand USD | 85.75% |
| 2015 Q3 | -261.97 Thousand USD | -15.85% |
| 2015 FY | -1.08 Million USD | -485.02% |
| 2015 Q1 | 99.11 Thousand USD | 1459.16% |
| 2015 Q2 | -226.12 Thousand USD | -328.14% |
| 2015 Q4 | -773.26 Thousand USD | -195.17% |
| 2014 Q3 | -202.38 Thousand USD | -264.06% |
| 2014 FY | -185.79 Thousand USD | -277.36% |
| 2014 Q4 | 6357.00 USD | 103.14% |
| 2014 Q1 | -113.12 Thousand USD | -8.63% |
| 2014 Q2 | 123.35 Thousand USD | 209.05% |
| 2013 FY | 104.75 Thousand USD | 297.28% |
| 2013 Q4 | -104.13 Thousand USD | -190.54% |
| 2013 Q3 | -35.84 Thousand USD | -113.83% |
| 2013 Q2 | 259.25 Thousand USD | 1885.0% |
| 2013 Q1 | -14.52 Thousand USD | -109.91% |
| 2012 Q3 | -184.82 Thousand USD | -262.56% |
| 2012 Q4 | 146.6 Thousand USD | 179.32% |
| 2012 FY | 26.36 Thousand USD | -96.06% |
| 2012 Q1 | -49.11 Thousand USD | -134.01% |
| 2012 Q2 | 113.69 Thousand USD | 331.48% |
| 2011 Q1 | 101.52 Thousand USD | -40.6% |
| 2011 Q2 | 178.64 Thousand USD | 75.97% |
| 2011 Q4 | 144.4 Thousand USD | -41.08% |
| 2011 Q3 | 245.08 Thousand USD | 37.19% |
| 2011 FY | 669.64 Thousand USD | -38.5% |
| 2010 Q1 | 251 Thousand USD | 32.32% |
| 2010 Q3 | 245.78 Thousand USD | -41.64% |
| 2010 Q4 | 170.92 Thousand USD | -30.46% |
| 2010 Q2 | 421.13 Thousand USD | 67.78% |
| 2010 FY | 1.08 Million USD | 53.92% |
| 2009 Q3 | 340.33 Thousand USD | 54.41% |
| 2009 Q1 | -43.03 Thousand USD | 99.4% |
| 2009 Q2 | 220.41 Thousand USD | 612.16% |
| 2009 FY | 707.4 Thousand USD | 107.59% |
| 2009 Q4 | 189.69 Thousand USD | -44.26% |
| 2008 Q1 | -982.07 Thousand USD | -517.29% |
| 2008 Q2 | -363.43 Thousand USD | 62.99% |
| 2008 Q3 | -859.8 Thousand USD | -136.57% |
| 2008 Q4 | -7.11 Million USD | -727.77% |
| 2008 FY | -9.32 Million USD | -7488.74% |
| 2007 FY | -122.84 Thousand USD | -141.5% |
| 2007 Q3 | -86.76 Thousand USD | -256.35% |
| 2007 Q1 | -247.07 Thousand USD | -4614.38% |
| 2007 Q2 | -24.34 Thousand USD | 90.14% |
| 2007 Q4 | 235.34 Thousand USD | 371.23% |
| 2006 FY | 296.01 Thousand USD | -76.28% |
| 2006 Q4 | 5473.00 USD | -91.06% |
| 2006 Q3 | 61.24 Thousand USD | -79.41% |
| 2006 Q2 | 297.44 Thousand USD | 536.49% |
| 2006 Q1 | -68.14 Thousand USD | -126.75% |
| 2005 Q4 | 254.71 Thousand USD | -11.46% |
| 2005 Q3 | 287.69 Thousand USD | -33.9% |
| 2005 FY | 1.24 Million USD | -18.15% |
| 2005 Q1 | 270.37 Thousand USD | -24.29% |
| 2005 Q2 | 435.25 Thousand USD | 60.98% |
| 2004 Q4 | 357.13 Thousand USD | -14.34% |
| 2004 Q2 | 452.37 Thousand USD | 51.64% |
| 2004 Q3 | 416.91 Thousand USD | -7.84% |
| 2004 FY | 1.52 Million USD | 662.3% |
| 2004 Q1 | 298.32 Thousand USD | 236.53% |
| 2003 FY | 200.01 Thousand USD | -74.17% |
| 2003 Q2 | 121.6 Thousand USD | -44.5% |
| 2003 Q1 | 219.12 Thousand USD | 12.97% |
| 2003 Q4 | -218.5 Thousand USD | -380.9% |
| 2003 Q3 | 77.78 Thousand USD | -36.03% |
| 2002 Q3 | 197.21 Thousand USD | 34.94% |
| 2002 FY | 774.34 Thousand USD | -5.57% |
| 2002 Q4 | 193.96 Thousand USD | -1.65% |
| 2002 Q2 | 146.14 Thousand USD | -38.34% |
| 2002 Q1 | 237.03 Thousand USD | 32.69% |
| 2001 Q2 | 148.12 Thousand USD | -45.79% |
| 2001 Q3 | 220.03 Thousand USD | 48.54% |
| 2001 Q4 | 178.64 Thousand USD | -18.81% |
| 2001 FY | 820.04 Thousand USD | 50.57% |
| 2001 Q1 | 273.24 Thousand USD | -48.23% |
| 2000 Q2 | - USD | -100.0% |
| 2000 Q3 | -107.52 Thousand USD | 0.0% |
| 2000 FY | 544.63 Thousand USD | -63.69% |
| 2000 Q1 | 100 Thousand USD | -50.0% |
| 2000 Q4 | 527.84 Thousand USD | 590.9% |
| 1999 Q2 | 400 Thousand USD | -50.0% |
| 1999 Q4 | 200 Thousand USD | 0.0% |
| 1999 FY | 1.5 Million USD | 36.36% |
| 1999 Q1 | 800 Thousand USD | 300.0% |
| 1999 Q3 | 200 Thousand USD | -50.0% |
| 1998 Q3 | 300 Thousand USD | 50.0% |
| 1998 FY | 1.1 Million USD | 83.33% |
| 1998 Q1 | 300 Thousand USD | 200.0% |
| 1998 Q2 | 200 Thousand USD | -33.33% |
| 1998 Q4 | 200 Thousand USD | -33.33% |
| 1997 Q4 | 100 Thousand USD | -50.0% |
| 1997 Q3 | 200 Thousand USD | 100.0% |
| 1997 Q1 | 200 Thousand USD | 166.67% |
| 1997 Q2 | 100 Thousand USD | -50.0% |
| 1997 FY | 600 Thousand USD | 200.0% |
| 1996 FY | 200 Thousand USD | -33.33% |
| 1996 Q4 | -300 Thousand USD | -400.0% |
| 1996 Q3 | 100 Thousand USD | -66.67% |
| 1996 Q2 | 300 Thousand USD | 400.0% |
| 1996 Q1 | -100 Thousand USD | 0.0% |
| 1995 FY | 300 Thousand USD | 150.0% |
| 1995 Q3 | 100 Thousand USD | -50.0% |
| 1995 Q2 | 200 Thousand USD | 100.0% |
| 1995 Q1 | 100 Thousand USD | 133.33% |
| 1995 Q4 | -100 Thousand USD | -200.0% |
| 1994 Q2 | 100 Thousand USD | 125.0% |
| 1994 Q1 | -400 Thousand USD | -500.0% |
| 1994 FY | -600 Thousand USD | -400.0% |
| 1994 Q4 | -300 Thousand USD | -400.0% |
| 1994 Q3 | 100 Thousand USD | 0.0% |
| 1993 Q4 | 100 Thousand USD | -50.0% |
| 1993 Q1 | 100 Thousand USD | 0.0% |
| 1993 FY | 200 Thousand USD | -71.43% |
| 1993 Q2 | - USD | -100.0% |
| 1993 Q3 | 200 Thousand USD | 0.0% |
| 1992 Q3 | 200 Thousand USD | -33.33% |
| 1992 Q2 | 300 Thousand USD | 50.0% |
| 1992 Q1 | 200 Thousand USD | 0.0% |
| 1992 Q4 | 100 Thousand USD | -50.0% |
| 1992 FY | 700 Thousand USD | 40.0% |
| 1991 Q2 | 100 Thousand USD | -50.0% |
| 1991 Q1 | 200 Thousand USD | 100.0% |
| 1991 Q4 | 200 Thousand USD | 0.0% |
| 1991 Q3 | 200 Thousand USD | 100.0% |
| 1991 FY | 500 Thousand USD | -16.67% |
| 1990 Q2 | 1.6 Million USD | 6.67% |
| 1990 Q4 | 100 Thousand USD | -50.0% |
| 1990 FY | 600 Thousand USD | -40.0% |
| 1990 Q1 | 1.5 Million USD | 134.09% |
| 1990 Q3 | 200 Thousand USD | -87.5% |
| 1989 Q1 | 1.5 Million USD | 0.0% |
| 1989 Q2 | 1.8 Million USD | 20.0% |
| 1989 FY | 1 Million USD | 0.0% |
| 1989 Q4 | -4.4 Million USD | -309.52% |
| 1989 Q3 | 2.1 Million USD | 16.67% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 84.172% |
| Cerus Corporation | -30.05 Million USD | 92.437% |
| OrthoPediatrics Corp. | -25.76 Million USD | 91.178% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 78.599% |
| Talis Biomedical Corporation | -66.81 Million USD | 96.598% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 86.858% |
| Inogen, Inc. | -109.38 Million USD | 97.922% |
| Spectral AI, Inc. | -12.98 Million USD | 82.493% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 96.368% |
| CVRx, Inc. | -43.1 Million USD | 94.726% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 35.571% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 81.71% |
| Orthofix Medical Inc. | -139.11 Million USD | 98.366% |
| Venus Concept Inc. | -28.3 Million USD | 91.971% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 95.793% |
| Bioventus Inc. | -81.72 Million USD | 97.219% |
| BrainsWay Ltd. | -4.92 Million USD | 53.865% |
| Envoy Medical, Inc. | -18.37 Million USD | 87.627% |
| electroCore, Inc. | -18.8 Million USD | 87.913% |
| IceCure Medical Ltd | -15.57 Million USD | 85.407% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 95.312% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 86.837% |
| MaxCyte, Inc. | -48.29 Million USD | 95.294% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 80.987% |
| Nexalin Technology, Inc. | -5.69 Million USD | 60.096% |
| PAVmed Inc | -68.79 Million USD | 96.696% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 95.981% |
| RxSight, Inc. | -50.08 Million USD | 95.462% |
| Sight Sciences, Inc. | -57.27 Million USD | 96.031% |
| SI-BONE, Inc. | -46.93 Million USD | 95.157% |
| TELA Bio, Inc. | -44.07 Million USD | 94.843% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 95.802% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 95.58% |
| LivaNova PLC | -68.49 Million USD | 96.682% |
| 908 Devices Inc. | -42.75 Million USD | 94.684% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 98.689% |
| Nemaura Medical Inc. | -9.59 Million USD | 76.311% |
| NeuroPace, Inc. | -27.17 Million USD | 91.635% |
| LENSAR, Inc. | -12.22 Million USD | 81.413% |
| Apyx Medical Corporation | -17.25 Million USD | 86.83% |
| Cutera, Inc. | -156.23 Million USD | 98.545% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | 73.581% |
| BioSig Technologies, Inc. | -28.51 Million USD | 92.028% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 97.406% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 89.873% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 102.038% |
| Axonics, Inc. | -26.05 Million USD | 91.277% |
| Outset Medical, Inc. | -169.77 Million USD | 98.661% |
| IRIDEX Corporation | -10 Million USD | 77.285% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 97.918% |
| IRadimed Corporation | 20.03 Million USD | 111.345% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 72.431% |
| INVO Bioscience, Inc. | -6.76 Million USD | 66.411% |
| Telesis Bio, Inc. | -35.15 Million USD | 93.533% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 115.862% |
| Varex Imaging Corporation | 32.1 Million USD | 107.081% |
| Quipt Home Medical Corp. | 3.91 Million USD | 158.001% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 81.266% |
| Pulmonx Corporation | -61.93 Million USD | 96.33% |
| Modular Medical, Inc. | -17.52 Million USD | 87.033% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 84.473% |
| Semler Scientific, Inc. | 22.25 Million USD | 110.213% |
| InMode Ltd. | 195.66 Million USD | 101.162% |
| Bruker Corporation | 436.9 Million USD | 100.52% |
| Cytosorbents Corporation | -31.2 Million USD | 92.717% |
| DexCom, Inc. | 597.7 Million USD | 100.38% |
| Align Technology, Inc. | 643.33 Million USD | 100.353% |
| Viveve Medical, Inc. | -21.55 Million USD | 89.454% |
| ZimVie Inc. | -30.93 Million USD | 92.653% |
| Movano Inc. | -29.69 Million USD | 92.344% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 91.837% |
| Nexalin Technology, Inc. | -5.69 Million USD | 60.096% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 35.571% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 99.025% |
| Profound Medical Corp. | -28.61 Million USD | 92.057% |
| Insulet Corporation | 220 Million USD | 101.033% |
| enVVeno Medical Corporation | -25.23 Million USD | 90.994% |
| Surmodics, Inc. | -5.64 Million USD | 59.733% |
| iCAD, Inc. | -7.68 Million USD | 70.438% |
| Nuwellis, Inc. | -17.63 Million USD | 87.107% |
| Biotricity, Inc. | -8.82 Million USD | 74.253% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 98.184% |
| Aethlon Medical, Inc. | -12.63 Million USD | 82.012% |
| InspireMD, Inc. | -21.14 Million USD | 89.249% |
| PAVmed Inc. | -68.79 Million USD | 96.696% |
| BIOLASE, Inc. | -17.93 Million USD | 87.328% |
| Beyond Air, Inc. | -63 Million USD | 96.392% |
| FONAR Corporation | 16.53 Million USD | 113.747% |
| AxoGen, Inc. | -21.46 Million USD | 89.409% |
| Vivani Medical, Inc. | -26.96 Million USD | 91.57% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 112.599% |
| Inari Medical, Inc. | -14.03 Million USD | 83.801% |
| UFP Technologies, Inc. | 57.66 Million USD | 103.942% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | 53.871% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | 63.953% |
| Tenon Medical, Inc. | -15.72 Million USD | 85.547% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | 69.587% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 94.677% |
| AdaptHealth Corp. | -598.4 Million USD | 99.62% |
| Sintx Technologies, Inc. | -13.35 Million USD | 82.984% |
| NanoVibronix, Inc. | -3.43 Million USD | 33.846% |
| Quanterix Corporation | -49.7 Million USD | 95.427% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 81.266% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -495.039% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 99.32% |
| TransMedics Group, Inc. | -28.72 Million USD | 92.087% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 90.373% |
| NeuroMetrix, Inc. | -7.15 Million USD | 68.216% |
| Hyperfine, Inc. | -48.11 Million USD | 95.276% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 96.504% |
| Biomerica, Inc. | -6.36 Million USD | 64.3% |
| Bone Biologics Corporation | -9.42 Million USD | 75.891% |
| AVITA Medical, Inc. | -40.4 Million USD | 94.374% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | 77.956% |
| Silk Road Medical, Inc | -59.27 Million USD | 96.165% |